(Q44119196)

30 November 2017

title

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity (English)

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

9 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

9 November 2022

author

Margaret W. Hilgartner

4

object named as

M Hilgartner

1 reference

30 November 2017

S. A. Tilley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724568

9 November 2022

W. J. Honnen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724568

9 November 2022

M. E. Racho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724568

9 November 2022

M. Hilgartner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724568

9 November 2022

A. Pinter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724568

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1724568

9 November 2022

publication date

1 July 1991

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:092325169190010Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

https://api.elsevier.com/content/article/PII:092325169190010Z?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

9 November 2022

1 reference

30 November 2017

volume

142

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

247-259

1 reference

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

30 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

A Film Detection Method for Tritium-Labelled Proteins and Nucleic Acids in Polyacrylamide Gels

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Isolation of a new human retrovirus from West African patients with AIDS.

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp 120 principal neutralizing domain

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

9 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides.

9 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

9 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Generation of human monoclonal antibodies to human immunodeficiency virus

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Envelope sequences of two new United States HIV-1 isolates

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

9 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Antibody-dependent enhancement of HIV infection

9 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

9 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Improved antigenicity of the HIV env protein by cleavage site removal

9 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

9 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

9 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

9 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

9 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

9 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

9 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion

9 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

O-linked glycosylation of retroviral envelope gene products

9 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

9 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection

9 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Complete nucleotide sequence of the AIDS virus, HTLV-III

9 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes

9 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

9 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell Lines

9 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro

9 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

9 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

9 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

9 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

9 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

Variable and conserved neutralization antigens of human immunodeficiency virus

9 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0923-2516(91)90010-Z

9 November 2022

Identifiers

1 reference

30 November 2017

1 reference